Clinical trial timelines in Switzerland are tightly linked to the efficiency of submissions to Swissmedic.
Delays at this stage do not remain confined to regulatory milestones. They cascade into site activation, contracts, budgets, and overall project duration.From a project-management perspective, Swissmedic approval is frequently on the critical path. Even minor, avoidable issues (missing annexes, outdated guidance, inconsistent documents) can postpone study start by weeks or months.